Related Experiment Video
Updated: Jul 16, 2026

Isolation of Whole Cell Protein Lysates from Mouse Facial Processes and Cultured Palatal Mesenchyme Cells for Phosphoprotein Analysis
Published on: April 1, 2022
Impaired FGF signaling contributes to cleft lip and palate
Bridget M Riley1, M Adela Mansilla, Jinghong Ma
1Department of Pediatrics, University of Iowa, Iowa City, IA 52242, USA.
Insights
Genetic disruptions in the FGF signaling pathway are linked to nonsyndromic cleft lip and palate (NS CLP). This study identified mutations and genetic associations, suggesting the pathway contributes to 3-5% of NS CLP cases.
Area of Science:
- Genetics
- Developmental Biology
- Craniofacial Development
Background:
- Nonsyndromic cleft lip and palate (NS CLP) is a complex birth defect with genetic and environmental origins.
- Fibroblast Growth Factor (FGF) and FGF Receptor (FGFR) genes are crucial for craniofacial development and mutations can cause clefting syndromes.
Purpose of the Study:
- To investigate the role of the FGF signaling pathway in the etiology of NS CLP.
- To identify genetic variants and associations within key FGF and FGFR genes in NS CLP patients.
Main Methods:
- Sequencing of coding regions for 12 genes (FGFR1-3, FGF2-4, FGF7-10, FGF18, NUDT6).
- Protein structure analysis to predict the functional impact of identified amino acid variants.
- Single Nucleotide Polymorphism (SNP) genotyping and association testing for NS CLP.
Main Results:
- Seven likely disease-causing mutations were identified, including nonsense and de novo missense mutations in FGFR1 and FGF8.
- Structural analysis indicated impaired protein function for variants in FGFR1, FGFR2, and FGF8.
- Association testing revealed significant links between NS CLP and SNPs in FGF3, FGF7, FGF10, FGF18, and FGFR1.
Conclusions:
- The FGF signaling pathway is implicated in a subset (3-5%) of NS CLP cases.
- Identified mutations and associations provide insights into the genetic basis of NS CLP.
- Findings suggest the FGF pathway should be considered in the clinical management of cleft lip and palate.
Abstract:
Nonsyndromic cleft lip and palate (NS CLP) is a complex birth defect resulting from a combination of genetic and environmental factors. Several members of the FGF and FGFR families are expressed during craniofacial development and can rarely harbor mutations that result in human clefting syndromes. We hypothesized that disruptions in this pathway might also contribute to NS CLP. We sequenced the coding regions and performed association testing on 12 genes (FGFR1, FGFR2, FGFR3, FGF2, FGF3, FGF4, FGF7, FGF8, FGF9, FGF10, FGF18, and NUDT6) and used protein structure analyses to predict the function of amino acid variants. Seven likely disease-causing mutations were identified, including: one nonsense mutation (R609X) in FGFR1, a de novo missense mutation (D73H) in FGF8, and other missense variants in FGFR1, FGFR2, and FGFR3. Structural analysis of FGFR1, FGFR2, and FGF8 variants suggests that these mutations would impair the function of the proteins, albeit through different mechanisms. Genotyping of SNPs in the genes found associations between NS CLP and SNPs in FGF3, FGF7, FGF10, FGF18, and FGFR1. The data suggest that the FGF signaling pathway may contribute to as much as 3-5% of NS CLP and will be a consideration in the clinical management of CLP.
Related Concept Videos
Notch Signaling Pathway
The Notch gene came into the limelight in 1914 after the discovery that its mutation in Drosophila melanogaster leads to a serrated (or "notched") wing margin phenotype. It was not until 1985...
Hedgehog Signaling Pathway
Role Of Notch Signalling In Intestinal Stem Cell Renewal
Direct cell-to-cell contact is needed for the activation of Notch signaling. The signal is initiated when a notch ligand binds to a receptor on an adjacent cell, also...
Pleiotropy
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...

